An Indian perspective on the use of fluticasone/formoterol in asthma and chronic obstructive pulmonary disease patients

An Indian perspective on the use of fluticasone/formoterol in asthma and chronic obstructive pulmonary disease patients

Despite rapidly evolving health-care systems, India continues to have a high disease burden for asthma and chronic obstructive pulmonary disease (COPD). The Asia-Pacific Asthma Insights and Management survey clearly revealed that asthma management remains very poor with worst clinical outcomes in In...

Full description

Bibliographic Details
Main Authors: Rahul Sharma, Zafar Ahmad Iqbal, Hemant Kalra, Abhinav Guliani, Anil K Singh, Akshay Budhraja, Gaurav Jain, Bharat Mehrotra, Loveleen Mangla, Avi Kumar, Vinay Purohit, Monika Chinda
Format: Article
Language:English
Published: Jaypee Brothers Medical Publisher 2021-01-01
Series:Indian Journal of Respiratory Care
Subjects:
asthma
chronic obstructive pulmonary disease
dual fluticasone and formoterol
dual inhaled corticosteroid–long-acting beta2-agonist
inhaler
Online Access:http://www.ijrc.in/article.asp?issn=2277-9019;year=2021;volume=10;issue=2;spage=196;epage=200;aulast=Sharma

Internet

http://www.ijrc.in/article.asp?issn=2277-9019;year=2021;volume=10;issue=2;spage=196;epage=200;aulast=Sharma

Similar Items